IL4I1 shows enhanced expression in a wide variety of tumor types [17,18], and its Trp-metabolizing activity yields various downstream metabolites which are associated with AhR agonism, including I3LA, I3AA, I3A and KynA [18,44,45,46]. The gene discussed is AHR; the disease is neoplasm.